Rising Awareness and Access Issues Are Shaping Demand 47% of GLP-1 users are aware of the FDA's new policy shift that has restricted the availability of compounded semaglutide on the market, and 17% say it's been harder to get their medication because of it
As of late August 2023, P.B
This steady glucose response encourages ongoing GLP-1 release in your gut, complementing your medication and keeping you feeling full longer
Its also important to spread out your protein intake throughout the day, including protein at every meal
Weekly semaglutide at 2.4 mg can achieve weight reductions of 10%12%, while tirzepatide has even demonstrated marked improvement in specific trials, reaching 5%20%+ ( More importantly, cardiovascular and renal outcome studies have demonstrated that GLP-1RAs and related multi-receptor agonists not only lower body weight and blood glucose but also significantly reduce the risk of major adverse cardiovascular events (MACE) and the worsening of renal function
That is one reason protein matters so much on a GLP-1 plan
